{"name":"TEVA PHARM","slug":"teva-pharm","ticker":"","exchange":"","domain":"tevapharm.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":69000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Cutivate","genericName":"FLUTICASONE PROPIONATE","slug":"fluticasone-propionate","revenue":69000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"1990-01-01","label":"Cutivate first approved","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"approval","sentiment":"positive"},{"date":"1991-01-01","label":"Cefzil first approved","drug":"Cefzil","drugSlug":"cefprozil","type":"approval","sentiment":"positive"},{"date":"2005-01-01","label":"Mycamine first approved","drug":"Mycamine","drugSlug":"micafungin","type":"approval","sentiment":"positive"},{"date":"2009-01-01","label":"Istodax first approved","drug":"Istodax","drugSlug":"romidepsin","type":"approval","sentiment":"positive"},{"date":"2012-01-01","label":"Synribo first approved","drug":"Synribo","drugSlug":"omacetaxine-mepesuccinate","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-08-26","label":"Cutivate patent expiry (Compound)","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"patent_expiry","sentiment":"negative"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2031-04-04","label":"Cutivate patent expiry (Method of Use)","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"patent_expiry","sentiment":"negative"},{"date":"2036-02-23","label":"Cutivate patent expiry (Method of Use)","drug":"Cutivate","drugSlug":"fluticasone-propionate","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":69000000,"percentOfTotal":100,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Cutivate","genericName":"FLUTICASONE PROPIONATE","slug":"fluticasone-propionate","indication":"Allergic asthma","status":"marketed","revenue":69000000},{"name":"Istodax","genericName":"ROMIDEPSIN","slug":"romidepsin","indication":"Cutaneous T-cell lymphoma (CTCL)","status":"marketed"},{"name":"Synribo","genericName":"OMACETAXINE MEPESUCCINATE","slug":"omacetaxine-mepesuccinate","indication":"Chronic myeloid leukemia","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":13,"colorKey":"cardiovascular","drugs":[{"name":"SHEUR","genericName":"ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX","slug":"elagolix-estradiol-and-norethindrone-acetate-and-elagolix","indication":"Other","status":"marketed"},{"name":"Activella®","genericName":"Activella®","slug":"activella","indication":"Other","status":"marketed"},{"name":"FEMCON® Fe","genericName":"FEMCON® Fe","slug":"femcon-fe","indication":"Contraception (prevention of pregnancy)","status":"marketed"},{"name":"Azelastine hydrochloride and Fluticasone propionate","genericName":"Azelastine hydrochloride and Fluticasone propionate","slug":"azelastine-hydrochloride-and-fluticasone-propionate","indication":"Other","status":"marketed"},{"name":"Biaxin®","genericName":"Biaxin®","slug":"biaxin","indication":"Other","status":"phase_1"},{"name":"Budesonide, Formoterol Fumarate Dihydrate","genericName":"Budesonide, Formoterol Fumarate Dihydrate","slug":"budesonide-formoterol-fumarate-dihydrate","indication":"Other","status":"marketed"},{"name":"Imvexxy","genericName":"Imvexxy","slug":"imvexxy","indication":"Other","status":"marketed"},{"name":"Lamictal®","genericName":"Lamictal®","slug":"lamictal","indication":"Other","status":"marketed"},{"name":"MabThera infusions","genericName":"MabThera infusions","slug":"mabthera-infusions","indication":"Other","status":"phase_1"},{"name":"Ovcon® 35 Fe","genericName":"Ovcon® 35 Fe","slug":"ovcon-35-fe","indication":"Other","status":"phase_1"},{"name":"Paxil®","genericName":"Paxil®","slug":"paxil","indication":"Other","status":"marketed"},{"name":"Topamax® Tablets","genericName":"Topamax® Tablets","slug":"topamax-tablets","indication":"Other","status":"phase_1"},{"name":"Zofran®","genericName":"Zofran®","slug":"zofran","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Mycamine","genericName":"MICAFUNGIN","slug":"micafungin","indication":"Candida Peritonitis","status":"marketed"},{"name":"Cefzil","genericName":"cefprozil","slug":"cefprozil","indication":"Acute Moraxella catarrhalis bronchitis","status":"marketed"},{"name":"Augmentin®","genericName":"Augmentin®","slug":"augmentin","indication":"Bacterial infections of the ear, nose, and throat","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"neuroscience","drugs":[{"name":"AKLIEF®","genericName":"AKLIEF®","slug":"aklief","indication":"Acne vulgaris","status":"marketed"},{"name":"Trifarotene 0.005 % Topical Cream","genericName":"Trifarotene 0.005 % Topical Cream","slug":"trifarotene-0-005-topical-cream","indication":"Acne vulgaris","status":"phase_3"},{"name":"YAZ®","genericName":"YAZ®","slug":"yaz","indication":"Contraception","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Trileptal®","genericName":"Trileptal®","slug":"trileptal","indication":"Partial-onset seizures (monotherapy and adjunctive therapy in adults and children)","status":"marketed"},{"name":"Imitrex®","genericName":"Imitrex®","slug":"imitrex","indication":"Acute treatment of migraine with or without aura","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"respiratory","drugs":[{"name":"VTAMA®","genericName":"VTAMA®","slug":"vtama","indication":"Plaque psoriasis","status":"marketed"},{"name":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","slug":"tapinarof-cream-1","indication":"Moderate to severe plaque psoriasis","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"rare","drugs":[{"name":"Cozaar®","genericName":"Cozaar®","slug":"cozaar","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"Cutivate","genericName":"FLUTICASONE PROPIONATE","slug":"fluticasone-propionate","phase":"marketed","mechanism":"Glucocorticoid receptor","indications":["Allergic asthma","Allergic rhinitis","Asthma management","Atopic dermatitis","Bronchospasm Prevention with COPD"],"catalyst":""},{"name":"Mycamine","genericName":"MICAFUNGIN","slug":"micafungin","phase":"marketed","mechanism":"ATP-binding cassette sub-family G member 2","indications":["Candida Peritonitis","Candidal septicemia","Candidemia","Candidiasis of the esophagus","Disseminated candidiasis"],"catalyst":""},{"name":"SHEUR","genericName":"ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX","slug":"elagolix-estradiol-and-norethindrone-acetate-and-elagolix","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"AKLIEF®","genericName":"AKLIEF®","slug":"aklief","phase":"marketed","mechanism":"Retinoic acid receptor alpha, Retinoic acid receptor beta, Retinoic acid receptor gamma","indications":["Acne vulgaris"],"catalyst":""},{"name":"Activella®","genericName":"Activella®","slug":"activella","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cefzil","genericName":"cefprozil","slug":"cefprozil","phase":"marketed","mechanism":"Small molecule","indications":["Acute Moraxella catarrhalis bronchitis","Acute bacterial bronchitis","Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute otitis media"],"catalyst":""},{"name":"FEMCON® Fe","genericName":"FEMCON® Fe","slug":"femcon-fe","phase":"marketed","mechanism":"FEMCON Fe is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and norethindrone, while the ferrous fumarate component replaces iron lost during menstruation.","indications":["Contraception (prevention of pregnancy)","Regulation of menstrual cycle"],"catalyst":""},{"name":"Istodax","genericName":"ROMIDEPSIN","slug":"romidepsin","phase":"marketed","mechanism":"Romidepsin inhibits HDACs, leading to increased acetylation of histones and non-histone proteins, causing cell cycle arrest and apoptosis in cancer cells.","indications":["Cutaneous T-cell lymphoma (CTCL)"],"catalyst":""},{"name":"Synribo","genericName":"OMACETAXINE MEPESUCCINATE","slug":"omacetaxine-mepesuccinate","phase":"marketed","mechanism":"Small molecule","indications":["Chronic myeloid leukemia"],"catalyst":""},{"name":"Trifarotene 0.005 % Topical Cream","genericName":"Trifarotene 0.005 % Topical Cream","slug":"trifarotene-0-005-topical-cream","phase":"phase_3","mechanism":"Trifarotene is a retinoic acid receptor gamma (RAR-gamma) agonist that modulates the expression of genes involved in cell differentiation and proliferation.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Trileptal®","genericName":"Trileptal®","slug":"trileptal","phase":"marketed","mechanism":"Oxcarbazepine blocks voltage-gated sodium channels in neuronal membranes, reducing repetitive neuronal firing and stabilizing hyperexcited neural tissue.","indications":["Partial-onset seizures (monotherapy and adjunctive therapy in adults and children)","Generalized tonic-clonic seizures (adjunctive therapy)","Bipolar disorder (off-label use)"],"catalyst":""},{"name":"VTAMA®","genericName":"VTAMA®","slug":"vtama","phase":"marketed","mechanism":"VTAMA is a topical retinoid that binds to and activates retinoid X receptors (RXR) to promote skin cell differentiation and reduce inflammation in psoriasis.","indications":["Plaque psoriasis"],"catalyst":""},{"name":"Augmentin®","genericName":"Augmentin®","slug":"augmentin","phase":"marketed","mechanism":"Augmentin combines amoxicillin (a beta-lactam antibiotic) with clavulanic acid (a beta-lactamase inhibitor) to kill bacteria and overcome antibiotic resistance.","indications":["Bacterial infections of the ear, nose, and throat","Respiratory tract infections","Urinary tract infections","Skin and soft tissue infections","Bone and joint infections"],"catalyst":""},{"name":"Azelastine hydrochloride and Fluticasone propionate","genericName":"Azelastine hydrochloride and Fluticasone propionate","slug":"azelastine-hydrochloride-and-fluticasone-propionate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Biaxin®","genericName":"Biaxin®","slug":"biaxin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Budesonide, Formoterol Fumarate Dihydrate","genericName":"Budesonide, Formoterol Fumarate Dihydrate","slug":"budesonide-formoterol-fumarate-dihydrate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cozaar®","genericName":"Cozaar®","slug":"cozaar","phase":"marketed","mechanism":"Cozaar blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.","indications":["Hypertension","Diabetic nephropathy in patients with type 2 diabetes","Heart failure with reduced ejection fraction","Stroke risk reduction in hypertensive patients with left ventricular hypertrophy"],"catalyst":""},{"name":"Imitrex®","genericName":"Imitrex®","slug":"imitrex","phase":"marketed","mechanism":"Imitrex is a selective serotonin 5-HT1B/1D receptor agonist that constricts cranial blood vessels and inhibits neuropeptide release to relieve migraine headaches.","indications":["Acute treatment of migraine with or without aura","Acute treatment of cluster headache"],"catalyst":""},{"name":"Imvexxy","genericName":"Imvexxy","slug":"imvexxy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lamictal®","genericName":"Lamictal®","slug":"lamictal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MabThera infusions","genericName":"MabThera infusions","slug":"mabthera-infusions","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Ovcon® 35 Fe","genericName":"Ovcon® 35 Fe","slug":"ovcon-35-fe","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paxil®","genericName":"Paxil®","slug":"paxil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","slug":"tapinarof-cream-1","phase":"phase_3","mechanism":"Tapinarof is a topical aryl hydrocarbon receptor agonist that modulates the immune response and reduces inflammation.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""},{"name":"Topamax® Tablets","genericName":"Topamax® Tablets","slug":"topamax-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"YAZ®","genericName":"YAZ®","slug":"yaz","phase":"marketed","mechanism":"YAZ is an oral contraceptive that prevents ovulation through a combination of ethinyl estradiol (estrogen) and drospirenone (progestin), while drospirenone also provides antimineralocorticoid activity.","indications":["Contraception","Acne vulgaris (FDA-approved indication)","Premenstrual dysphoric disorder (PMDD)"],"catalyst":""},{"name":"Zofran®","genericName":"Zofran®","slug":"zofran","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"7500444","type":"Formulation","expiryDate":"2026-02-26","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"7500444*PED","type":"Compound","expiryDate":"2026-08-26","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"12083270","type":"Method of Use","expiryDate":"2031-04-04","territory":"US","annualRevenue":69000000,"genericFilings":[]},{"drugName":"Cutivate","drugSlug":"fluticasone-propionate","patentNumber":"11554229","type":"Method of Use","expiryDate":"2036-02-23","territory":"US","annualRevenue":69000000,"genericFilings":[]}],"drugCount":27,"phaseCounts":{"marketed":21,"phase_3":2,"phase_1":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}